Story perspectives

Psilocybin Shows Promise for OCD, Cannabis Falls Short

12/13/2025

50 9

Summary

Story summary

Dr. Michael Van Ameringen of McMaster University led a review that found psilocybin shows promise for obsessive-compulsive disorder (OCD), while cannabis does not.
The review notes that 40–60% of OCD patients experience limited relief from traditional treatments.
Dr. Terrence Ching of Yale University says psilocybin may induce deeper perceptual changes than cannabis, which offers temporary relief.
Psilocybin remains a Schedule I substance in the United States, complicating research.

1 of 1

Story summary

Dr. Michael Van Ameringen of McMaster University led a review that found psilocybin shows promise for obsessive-compulsive disorder (OCD), while cannabis does not.
The review notes that 40–60% of OCD patients experience limited relief from traditional treatments.
Dr. Terrence Ching of Yale University says psilocybin may induce deeper perceptual changes than cannabis, which offers temporary relief.
Psilocybin remains a Schedule I substance in the United States, complicating research.